Introduction
Autoimmune liver diseases (AILD), encompassing autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC) have been linked with increased long-term cardiovascular risk, potentially through chronic systemic inflammation. Whether AILD is associated with worse outcomes after coronary revascularization is unknown.
Aims & Methods
In this nationwide, population-based cohort study, we identified all adults with AILD who underwent percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) for acute or elective coronary indications in Switzerland between 2012 and 2022. Patients with AILD were propensity score-matched 1:10 to comparators without AILD to balance baseline covariates. The primary outcome was major adverse cardiac events (MACE), defined as a composite of acute myocardial infarction, stroke, hospitalization for heart failure, or all-cause mortality. Secondary outcomes included each individual MACE component. Follow-up began at hospital discharge after coronary revascularization and was censored at the first outcome event, death, or end of follow-up (December 31, 2022), whichever occurred first. Hazard ratios (HRs) and incidence rates (IRs) were calculated using Cox proportional hazards modeling.
Results
The cohort included 171 patients with AILD (AIH, n=82; PBC, n=88; PSC, n=8) and 1,680 matched comparators without AILD. Over a median follow-up of 3.9 years (interquartile range [IQR], 1.1–6.8), MACE occurred more frequently in patients with AILD than in matched comparators (59.6% vs. 45.9%; IR, 115.8 vs. 78.4 per 10,000 person-years), corresponding to a 49% higher hazard (HR, 1.49; 95% confidence interval [CI], 1.20–1.86). AILD was associated with increased hazards of hospitalization for heart failure (HR, 1.73; 95% CI, 1.32–2.26) and all-cause mortality (HR, 1.53; 95% CI, 1.14–2.04). Hazards for acute myocardial infarction (HR, 1.42; 95% CI, 0.98–2.07) and stroke (HR, 1.62; 95% CI, 0.88–2.98) were numerically higher but missed statistical significance. Associations were robust in sensitivity analyses and consistent across all subtypes of AILD and appeared more pronounced in men than in women.
Conclusion
Among patients undergoing coronary revascularization, AILD was associated with a 49% higher hazard of MACE, primarily driven by higher rates of hospitalization for heart failure and all-cause mortality. These findings identify AILD as a potential inflammatory risk enhancer after coronary revascularization and suggest intensified secondary prevention and closer post-procedural follow-up